S&P 500   3,236.50 (-2.50%)
DOW   26,805.31 (-3.08%)
QQQ   263.67 (-1.20%)
AAPL   106.92 (+0.07%)
MSFT   199.57 (-0.41%)
FB   246.80 (-2.27%)
GOOGL   1,423.32 (-1.91%)
AMZN   2,891.57 (-2.14%)
NVDA   490.49 (+0.60%)
TSLA   440.96 (-0.27%)
BABA   270.89 (-0.56%)
CGC   15.57 (-4.83%)
GE   6.25 (-9.16%)
MU   48.87 (-3.69%)
AMD   76.46 (+2.04%)
T   28.31 (-2.14%)
F   6.86 (-5.12%)
ACB   6.34 (-2.91%)
GILD   63.61 (-2.21%)
NFLX   478.96 (+1.92%)
DIS   124.37 (-3.31%)
BAC   24.11 (-4.36%)
BA   156.61 (-2.81%)
S&P 500   3,236.50 (-2.50%)
DOW   26,805.31 (-3.08%)
QQQ   263.67 (-1.20%)
AAPL   106.92 (+0.07%)
MSFT   199.57 (-0.41%)
FB   246.80 (-2.27%)
GOOGL   1,423.32 (-1.91%)
AMZN   2,891.57 (-2.14%)
NVDA   490.49 (+0.60%)
TSLA   440.96 (-0.27%)
BABA   270.89 (-0.56%)
CGC   15.57 (-4.83%)
GE   6.25 (-9.16%)
MU   48.87 (-3.69%)
AMD   76.46 (+2.04%)
T   28.31 (-2.14%)
F   6.86 (-5.12%)
ACB   6.34 (-2.91%)
GILD   63.61 (-2.21%)
NFLX   478.96 (+1.92%)
DIS   124.37 (-3.31%)
BAC   24.11 (-4.36%)
BA   156.61 (-2.81%)
S&P 500   3,236.50 (-2.50%)
DOW   26,805.31 (-3.08%)
QQQ   263.67 (-1.20%)
AAPL   106.92 (+0.07%)
MSFT   199.57 (-0.41%)
FB   246.80 (-2.27%)
GOOGL   1,423.32 (-1.91%)
AMZN   2,891.57 (-2.14%)
NVDA   490.49 (+0.60%)
TSLA   440.96 (-0.27%)
BABA   270.89 (-0.56%)
CGC   15.57 (-4.83%)
GE   6.25 (-9.16%)
MU   48.87 (-3.69%)
AMD   76.46 (+2.04%)
T   28.31 (-2.14%)
F   6.86 (-5.12%)
ACB   6.34 (-2.91%)
GILD   63.61 (-2.21%)
NFLX   478.96 (+1.92%)
DIS   124.37 (-3.31%)
BAC   24.11 (-4.36%)
BA   156.61 (-2.81%)
S&P 500   3,236.50 (-2.50%)
DOW   26,805.31 (-3.08%)
QQQ   263.67 (-1.20%)
AAPL   106.92 (+0.07%)
MSFT   199.57 (-0.41%)
FB   246.80 (-2.27%)
GOOGL   1,423.32 (-1.91%)
AMZN   2,891.57 (-2.14%)
NVDA   490.49 (+0.60%)
TSLA   440.96 (-0.27%)
BABA   270.89 (-0.56%)
CGC   15.57 (-4.83%)
GE   6.25 (-9.16%)
MU   48.87 (-3.69%)
AMD   76.46 (+2.04%)
T   28.31 (-2.14%)
F   6.86 (-5.12%)
ACB   6.34 (-2.91%)
GILD   63.61 (-2.21%)
NFLX   478.96 (+1.92%)
DIS   124.37 (-3.31%)
BAC   24.11 (-4.36%)
BA   156.61 (-2.81%)
Log in
NASDAQ:OGI

OrganiGram Stock Forecast, Price & News

$1.19
+0.05 (+4.39 %)
(As of 09/21/2020 02:14 PM ET)
Add
Compare
Today's Range
$1.10
Now: $1.19
$1.24
50-Day Range
$1.06
MA: $1.25
$1.47
52-Week Range
$1.04
Now: $1.19
$4.35
Volume106,688 shs
Average Volume4.48 million shs
Market Capitalization$231.47 million
P/E RatioN/A
Dividend YieldN/A
Beta0.04
OrganiGram Holdings Inc., through its subsidiaries, produces and sells dried cannabis and cannabis oil in Canada. It also offers wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis oils to retailers and wholesalers. The company also exports its products. It sells its products online, as well as through phone orders. OrganiGram Holdings Inc. was founded in 2013 and is headquartered in Moncton, Canada.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 4.2Community Rank: 3.1Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.59 out of 5 stars


Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:OGI
CUSIPN/A
CIKN/A
Phone1-855-961-9420

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$61.27 million
Cash Flow$0.11 per share
Book Value$1.58 per share

Profitability

Net Income$-7,200,000.00
Net Margins-142.02%

Miscellaneous

Employees615
Market Cap$231.47 million
Next Earnings Date11/24/2020 (Estimated)
OptionableNot Optionable
$1.19
+0.05 (+4.39 %)
(As of 09/21/2020 02:14 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive OGI News and Ratings via Email

Sign-up to receive the latest news and ratings for OGI and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











OrganiGram (NASDAQ:OGI) Frequently Asked Questions

How has OrganiGram's stock been impacted by Coronavirus (COVID-19)?

OrganiGram's stock was trading at $1.72 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, OGI stock has decreased by 31.4% and is now trading at $1.18.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of OrganiGram?

15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for OrganiGram in the last year. There are currently 9 hold ratings and 6 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for OrganiGram
.

When is OrganiGram's next earnings date?

OrganiGram is scheduled to release its next quarterly earnings announcement on Tuesday, November 24th 2020.
View our earnings forecast for OrganiGram
.

How were OrganiGram's earnings last quarter?

OrganiGram Holdings Inc (NASDAQ:OGI) issued its quarterly earnings results on Tuesday, July, 21st. The company reported ($0.51) earnings per share for the quarter, missing analysts' consensus estimates of ($0.02) by $0.49. The company earned $22.24 million during the quarter, compared to analysts' expectations of $20.83 million. OrganiGram had a negative net margin of 142.02% and a negative return on equity of 4.88%. The company's quarterly revenue was down 26.7% on a year-over-year basis. During the same quarter in the prior year, the business earned ($0.07) EPS.
View OrganiGram's earnings history
.

What price target have analysts set for OGI?

15 brokers have issued 12-month target prices for OrganiGram's stock. Their forecasts range from $1.72 to $8.50. On average, they expect OrganiGram's share price to reach $3.76 in the next twelve months. This suggests a possible upside of 219.0% from the stock's current price.
View analysts' price targets for OrganiGram
.

Are investors shorting OrganiGram?

OrganiGram saw a increase in short interest in August. As of August 14th, there was short interest totaling 15,230,000 shares, an increase of 9.2% from the July 30th total of 13,950,000 shares. Based on an average daily volume of 5,800,000 shares, the short-interest ratio is currently 2.6 days. Approximately 7.9% of the shares of the stock are sold short.
View OrganiGram's Short Interest
.

Who are some of OrganiGram's key competitors?

What other stocks do shareholders of OrganiGram own?

Based on aggregate information from My MarketBeat watchlists, some companies that other OrganiGram investors own include KushCo (KSHB), Canopy Growth (CGC), Auxly Cannabis Group (CBWTF), Supreme Cannabis (SPRWF), Medical Marijuana (MJNA), Cannabics Pharmaceuticals (CNBX), Marimed (MRMD), Aurora Cannabis (ACB), EVIO (EVIO) and Gran Tierra Energy (GTE).

Who are OrganiGram's key executives?

OrganiGram's management team includes the following people:
  • Mr. Greg Engel, CEO & Director (Age 54)
  • Mr. Paolo De Luca C.A., C.F.A, Chief Financial Officer (Age 46)
  • Mr. Jeff Purcell, VP - Operations
  • Mr. Timothy Emberg, Sr. VP of Sales & Commercial Operations
  • Mr. Peter R. Hanson, Director of Fin.

What is OrganiGram's stock symbol?

OrganiGram trades on the NASDAQ under the ticker symbol "OGI."

Who are OrganiGram's major shareholders?

OrganiGram's stock is owned by a number of retail and institutional investors. Top institutional shareholders include AdvisorShares Investments LLC (0.70%), Swiss National Bank (0.21%), Ancora Advisors LLC (0.17%), TD Asset Management Inc. (0.08%), Goldman Sachs Group Inc. (0.06%) and Commonwealth Equity Services LLC (0.05%).

Which institutional investors are selling OrganiGram stock?

OGI stock was sold by a variety of institutional investors in the last quarter, including Bank of America Corp DE, Jane Street Group LLC, Commonwealth Equity Services LLC, Bank of Montreal Can, and Ancora Advisors LLC.

Which institutional investors are buying OrganiGram stock?

OGI stock was acquired by a variety of institutional investors in the last quarter, including AdvisorShares Investments LLC, Swiss National Bank, WFA of San Diego LLC, WFA of San Diego LLC, Goldman Sachs Group Inc., XTX Markets LLC, and TD Asset Management Inc..

How do I buy shares of OrganiGram?

Shares of OGI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is OrganiGram's stock price today?

One share of OGI stock can currently be purchased for approximately $1.18.

How big of a company is OrganiGram?

OrganiGram has a market capitalization of $229.52 million and generates $61.27 million in revenue each year. The company earns $-7,200,000.00 in net income (profit) each year or $0.06 on an earnings per share basis. OrganiGram employs 615 workers across the globe.

What is OrganiGram's official website?

The official website for OrganiGram is www.organigram.ca.

How can I contact OrganiGram?

OrganiGram's mailing address is 35 English Dr., Moncton Z4, E1E 3X3. The company can be reached via phone at 1-855-961-9420.

This page was last updated on 9/21/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.